- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
PHP
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Primary Health Properties Plc · Real Estate · Reit - Healthcare Facilities
Latest close
0.96 GBP
1.5%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.3% above the Trend Line and sits at 60.2% of its 52-week range. The latest completed week returned 1.5%, after a 3.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100.
Setup score
54
out of 100
Latest Close
0.96 GBP
7 Aug 2026
1W Return
1.5%
latest completed week
4W Return
3.0%
short-term follow-through
12W Return
7.2%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.5%
Latest completed week; four-week move 3.0%.
Indicator stack
15/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
55/100
23 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.3% above the Trend Line and sits at 60.2% of its 52-week range. The latest completed week returned 1.5%, after a 3.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2112-week average 0.17
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.21Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 3.0% over four weeks, 7.2% over 12 weeks, and 9.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.66Latest activity-pressure read.
Pressure change674.3%Four-week change in activity pressure.
Leadership-3.72Latest relative-leadership reading.
RS change-0.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 67%
Model confidence 53%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength34/100Blend of value, momentum, and quality. Underlying universe rank 67; rank 1 is best.
Value38/100Relative valuation strength. Underlying universe rank 63; rank 1 is best.
Quality39/100Profitability and accounting quality. Underlying universe rank 62; rank 1 is best.
Momentum40/100Medium-term price momentum. Underlying universe rank 61; rank 1 is best.
Growth40/100Revenue and earnings growth. Underlying universe rank 61; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 0.2x Price divided by trailing earnings.
- Price / sales
- 0.1x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 5.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- 79.9% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 140.9% Latest one-year revenue growth.
- EPS growth
- 49.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 31.6% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- - Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 23 relevant articles.
5 positive · 18 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.0%Distance below the 52-week high.
13-week volatility2.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+4.9%Week of 26 Jun.
Worst week-7.3%Week of 20 Mar.
Latest week+1.5%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains11
Flat weeks0
Modest losses10
Sharp losses3
Recent vol2.2%13-week weekly-return volatility.
Base vol2.8%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -2.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Real Estate
4-week rank22 / 53
Group average3.4%
Trend breadth28.3%
Trend28.3%active weekly trend signals
MD69.8%positive activity pressure
RS18.9%positive relative leadership
Four-week leaders
IndustryGB Reit - Healthcare Facilities
4-week rank1 / 1
Group average3.0%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis19/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.21; No reversal markers Factors37/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 32; Buyback Yield rank 64 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 23 relevant articles.
How Primary Health Properties (LSE:PHP) And Smith & Nephew (LSE:SN) Put Healthcare Stocks Back On The London Watchlist Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.96 GBP | 1.5% | 0.95 GBP | 0.85 GBP | 0.66 | -3.72 | 62.9M | Off |
| 31 Jul 2026 | 0.94 GBP | -0.2% | 0.95 GBP | 0.85 GBP | 0.48 | -5.04 | 83.2M | Off |
| 24 Jul 2026 | 0.95 GBP | 0.2% | 0.95 GBP | 0.85 GBP | 0.27 | -3.90 | 45.4M | Off |
| 17 Jul 2026 | 0.94 GBP | 1.5% | 0.95 GBP | 0.85 GBP | 0.17 | -3.05 | 43.0M | Off |
| 10 Jul 2026 | 0.93 GBP | -0.9% | 0.94 GBP | 0.85 GBP | -0.12 | -3.70 | 36.6M | Off |
| 3 Jul 2026 | 0.94 GBP | -1.1% | 0.94 GBP | 0.85 GBP | -0.42 | -4.74 | 7.1M | Off |
| 26 Jun 2026 | 0.95 GBP | 4.9% | 0.94 GBP | 0.85 GBP | -0.72 | -2.42 | 7.6M | Off |
| 19 Jun 2026 | 0.90 GBP | -0.4% | 0.94 GBP | 0.84 GBP | -0.94 | -5.97 | 36.1M | Off |
| 12 Jun 2026 | 0.91 GBP | 2.5% | 0.94 GBP | 0.84 GBP | -1.00 | -6.98 | 9.3M | Off |
| 5 Jun 2026 | 0.89 GBP | -3.8% | 0.94 GBP | 0.84 GBP | -0.98 | -8.70 | 51.8M | Off |
| 29 May 2026 | 0.92 GBP | 0.7% | 0.94 GBP | 0.84 GBP | -0.92 | -5.81 | 55.7M | Off |
| 22 May 2026 | 0.91 GBP | 2.2% | 0.94 GBP | 0.84 GBP | -0.86 | -7.27 | 49.9M | Off |
| 15 May 2026 | 0.89 GBP | -2.9% | 0.94 GBP | 0.84 GBP | -0.81 | -7.15 | 55.7M | Off |
| 8 May 2026 | 0.92 GBP | -0.5% | 0.94 GBP | 0.84 GBP | -0.76 | -5.09 | 49.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.